Shanghai Rendu Biotechnology Co Stock

Shanghai Rendu Biotechnology Co Liabilities

The The Liabilities of Shanghai Rendu Biotechnology Co (688193.SS) as of Aug 5, 2026 is 82.00 M CNY. In the previous year, The Liabilities was 92.00 M CNY — a change of -10.87% (lower).

Liabilities

82.00 MCNY

YoY

-10.87%

Last updated:

In 2026, Shanghai Rendu Biotechnology Co's total liabilities amounted to 82.00 M CNY, a -10.87% difference from the 92.00 M CNY total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Shanghai Rendu Biotechnology Co's Liabilities

Shanghai Rendu Biotechnology Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Shanghai Rendu Biotechnology Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Shanghai Rendu Biotechnology Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Shanghai Rendu Biotechnology Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Shanghai Rendu Biotechnology Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

The Liabilities of Shanghai Rendu Biotechnology Co is 82.00 M CNY in 2026.

The Liabilities of Shanghai Rendu Biotechnology Co changed from 92.00 M CNY to 82.00 M CNY, representing a -10.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Shanghai Rendu Biotechnology Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Shanghai Rendu Biotechnology Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Shanghai Rendu Biotechnology Co